| Ticker Details |
|
Revolution Medicines, Inc.
|
| IPO Date: |
February 13, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$32.22B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.92 | 2.60%
|
| Avg Daily Range (30 D): |
$3.26 | 2.26%
|
| Avg Daily Range (90 D): |
$2.10 | 1.75%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.02M |
| Avg Daily Volume (30 D): |
3.1M |
| Avg Daily Volume (90 D): |
2.29M |
| Trade Size |
| Avg Trade Size (Sh.): |
69 |
| Avg Trade Size (Sh.) (30 D): |
67 |
| Avg Trade Size (Sh.) (90 D): |
62 |
| Institutional Trades |
| Total Institutional Trades: |
6,233 |
| Avg Institutional Trade: |
$4.26M |
| Avg Institutional Trade (30 D): |
$9.87M |
| Avg Institutional Trade (90 D): |
$9.48M |
| Avg Institutional Trade Volume: |
.09M |
| Avg Institutional Trades (Per Day): |
4 |
| Market Closing Trades |
| Avg Closing Trade: |
$9.41M |
| Avg Closing Trade (30 D): |
$57.23M |
| Avg Closing Trade (90 D): |
$47.21M |
| Avg Closing Volume: |
202.38K |
|
|
| News |
May 19, 2026 @ 10:53 PM
ERASCA INVESTOR ALERT: Bragar Eagel & Squire, P.C....
Source: Bragar Eagel & Squire, P.C.
|
May 15, 2026 @ 3:47 PM
Cancer Centers Race To Access Revolution Medicines...
Source: Vandana Singh
|
May 14, 2026 @ 9:52 PM
ERASCA INVESTOR ALERT: Bragar Eagel & Squire, P.C....
Source: Bragar Eagel & Squire, P.C.
|
May 10, 2026 @ 11:29 PM
ERAS Investors Have Opportunity to Join Erasca, In...
Source: Schall Law Firm
|
May 6, 2026 @ 10:00 PM
Revolution Medicines Announces Publication in New ...
Source: Revolution Medicines
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-7.1
|
$-2.29
|
$-1.89
|
|
Diluted EPS
|
$-7.1
|
$-2.29
|
$-1.89
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-1371.7M
|
$-453.82M
|
$-364.89M
|
|
Operating Income / Loss
|
$-1386.83M
|
$-445.22M
|
$-361.63M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$108.55M
|
$57.19M
|
$166.3M
|
|
PE Ratio
|
|
|
|
|
|
|
